The European Innovative Medicines Initiative

Article type: Research Article

Authors: Ruberti, Giovina

Affiliations: Istituto di Biologia Cellulare – Consiglio Nazionale delle Ricerche (CNR), Rome, Italy. E-mail: [email protected]

Abstract: The Innovative Medicines Initiative is a unique and novel long term european public-private partnership designed by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The initiative was promoted to accelerate the discovery and development of better medicines by removing bottlenecks in the drug development process. It focuses on creating better methods and tools that improve and enhance the drug development process, rather than on developing specific, new medicines.

Keywords: Innovative Medicines Initiative, Joint Technology Initiative, R&D investment, European Federation of Pharmaceutical Industries and Associations

DOI: 10.3233/PPL-2010-0259

Journal: Pharmaceuticals, Policy and Law, vol. 12, no. 1-2, pp. 19-24, 2010